131 participants
A Study of Pegylated Interferon Alfa-2a and Lamivudine in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2016-11-03
- Start Date:
- 2005-02-28
- Completion:
- 2010-01-31
Conditions
- Hepatitis B, Chronic
Interventions
- DRUG